CRChristopher Rayner

Christopher Rayner

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Christopher Rayner has a total of 254 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Attrition in the Twins Early Development Study: predictors, consequences, and corrections

    by Giacomo Bignardi, Thalia Catherine Eley, Celestine Laetitia Lockhart, Christopher Rayner, Kate Tilling, Tom McAdams

    BackgroundAttrition in longitudinal studies often leads to healthier, more educated and less demographically representative samples at follow-up. The extent to which attrition impacts results from twin studies, and the efficacy of methods to correct for attrition, remains unclear. MethodsWe address these questions using data from the Twins Early Development Study (TEDS). First, we found that baseline variables, including twin sex, zygosity, ethnicity and maternal socioeconomic status, predicted 5–7.5% of the variance in follow-up participation. Next, we examined the impact of attrition by comparing estimated means, variances, correlations, and genetic and environmental influences before and after removing participants who did not participate at follow-up. We evaluated a range of twin measures from the Year 2, 12 and 16 time points, including internalising, externalising, educational and cognitive measures. ResultsAttrition affected means and variances, but had little material effect on correlations and genetic and environmental variance components. Finally, we evaluated the efficacy of two popular correction methods—inverse probability weighting and multiple imputation—to reduce bias, focusing on adolescent outcomes. Both methods partially reduced bias in mean estimates; however, imputation also introduced bias for some effects. ConclusionsOur results suggest that for the variables we examined in TEDS, correlations and genetic and environmental variance components are not strongly impacted by attrition. Imputation and weighting methods can reduce attrition bias when estimating means and variances but may introduce bias into estimates of association.

  • Open Access

    Genetic Exploration of Depression Onset in Females from Menarche to Menopause

    by Hannah Oppenheimer, Maria Viejo-Romero, Louise Schindler, Arielle Crestol, Dennis van der Meer, Christopher Rayner, Jared Gichohi Maina, Lars T. Westlye, Ann-Marie G de Lange, David M Howard, et al.

    Depression risk in females is markedly elevated during hormonal transitions such as menarche, the perinatal period, and menopause; yet the genetic basis of depression onset during these windows remains uncharacterized. We conducted GWAS meta-analyses (including the X chromosome) in females from Generation Scotland and UK Biobank, running the first GWAS of depression onset around menarche (ncases = 3,089; ncontrols = 25,558) and around natural menopause (ncases = 3,754; ncontrols = 14,079), and the largest female-specific GWAS of continuous age at onset of depression (N = 29,735). We identified one locus for depression onset around menarche and two for depression onset around menopause, including one mapping onto CDKAL1, a gene implicated in metabolic disorders, and no genome-wide significant findings for continuous age at onset. Genetic correlation analyses revealed moderate to strong positive correlations among depression onset around menarche, around menopause, and postpartum depression (rg = 0.47-0.95), suggesting possible shared genetic pathways of reproductive-related depressions. Mendelian randomization demonstrated a causal effect of earlier menarche on depression onset around menarche; by contrast, age at menopause did not causally influence depression onset around menopause. Together, these findings establish a partly shared and partly distinct genetic architecture across reproductive-related depression subtypes, implicate possible metabolic pathways in depression onset around menopause, and provide a genetic framework for understanding why hormonal transitions confer differential depression risk across the female lifespan. By shifting focus from lifetime risk to hormonally defined onset windows, this study advances a timing informed genetic framework for understanding sex differences in depression.

  • Open Access

    Quantifying and adjusting for selection biases in the Norwegian Mother, Father and Child Cohort Study using population-wide individual-level registry information

    by Christopher Rayner, Laurie John Hannigan, Isabella Badini, Perline Demange, Sverre Berg Ofstad, Eivind Ystrom, Tom McAdams

    Background: Selective participation in research studies hampers researchers’ ability to draw valid and generalizable inferences from analyses. Quantifying and adjusting for selective participation is desirable, but can be challenging given the paucity of data for non-participants. Methods: We used individual-level information from population registers to predict baseline and continued participation in the Norwegian Mother, Father and Child Cohort Study (MoBa). Inverse probability weights were computed from logistic regression models with elastic-net regularization. We predicted selective participation and attrition in 296,987 mothers, of whom 29% returned the first MoBa questionnaire, and 12.5% who returned a follow-up questionnaire eight years later. To quantify bias we computed sample characteristics and outcome-exposure associations in the target population and stratified samples. To compare approaches for adjusting for bias, we computed weighted sample estimates using three sets of weights. Results: Unweighted sample estimates were systematically different from target population values, indicating bias due to selective participation. Baseline participation weights substantially reduced the impact of selection bias on mean values (93%) and associations (75%). Attrition weights performed similarly in reducing attrition bias (78% and 50%), but were less effective for reducing participation bias (22% and 14%). Discussion: Sample characteristics and effect estimates are substantially different from target population values. Participation weights were relatively effective at reducing bias due to selective participation, but attrition weights were not. Estimates from studies that use attrition weights may still contain non-negligible selection bias - particularly if the baseline sample is not representative of the target population. Future studies should prioritise opportunities for deriving sampling weights for participation as well as attrition.

  • Open Access

    Genetic overlap between functional impairment and depression and anxiety symptom severity: evidence from the GLAD Study

    by Megan Skelton, Jessica Mundy, Abigail R. ter Kuile, Brett N. Adey, Chérie Armour, Joshua E. J. Buckman, Jonathan R. I. Coleman, Molly R. Davies, Colette R. Hirsch, Matthew Hotopf, et al.

    Background: Functional impairment in daily activities, such as work and socializing, is part of the diagnostic criteria for major depressive disorder and most anxiety disorders. Despite evidence that symptom severity and functional impairment are partially distinct, functional impairment is often overlooked. To assess whether functional impairment captures diagnostically relevant genetic liability beyond that of symptoms, we aimed to estimate the heritability of, and genetic correlations between, key measures of current depression symptoms, anxiety symptoms, and functional impairment. Methods: In 17,130 individuals with lifetime depression or anxiety from the Genetic Links to Anxiety and Depression (GLAD) Study, we analyzed total scores from the Patient Health Questionnaire-9 (depression symptoms), Generalized Anxiety Disorder-7 (anxiety symptoms), and Work and Social Adjustment Scale (functional impairment). Genome-wide association analyses were performed with REGENIE. Heritability was estimated using GCTA-GREML and genetic correlations with bivariate-GREML. Results: The phenotypic correlations were moderate across the three measures (Pearson’s r = 0.50–0.69). All three scales were found to be under low but significant genetic influence (single-nucleotide polymorphism-based heritability [h2SNP] = 0.11–0.19) with high genetic correlations between them (rg = 0.79–0.87). Conclusions: Among individuals with lifetime depression or anxiety from the GLAD Study, the genetic variants that underlie symptom severity largely overlap with those influencing functional impairment. This suggests that self-reported functional impairment, while clinically relevant for diagnosis and treatment outcomes, does not reflect substantial additional genetic liability beyond that captured by symptom-based measures of depression or anxiety.


  • Open Access

    Genetic overlap between functional impairment and depression and anxiety symptom severity: Evidence from the GLAD Study

    by Megan Skelton, Jessica Mundy, Abigail ter Kuile, Brett N Adey, Cherie Armour, Joshua Eusty Jonathan Buckman, Jonathan Richard Iain Coleman, Molly Rose Davies, Colette Hirsch, Matthew Hotopf, et al.

    Background Functional impairment in daily activities, such as work and socialising, is part of the diagnostic criteria for major depressive disorder (MDD) and most anxiety disorders. Despite evidence that symptom severity and functional impairment are partially distinct, functional impairment is often overlooked. To assess whether functional impairment captures diagnostically relevant genetic liability beyond that of symptoms, we aimed to estimate the heritability of, and genetic correlations between, key measures of current depression symptoms, anxiety symptoms and functional impairment. Methods In 17,130 individuals with lifetime depression or anxiety from the Genetic Links to Anxiety and Depression (GLAD) Study, we analysed total scores from the Patient Health Questionnaire-9 (PHQ-9; depression symptoms), Generalised Anxiety Disorder-7 (GAD-7; anxiety symptoms), and Work and Social Adjustment Scale (WSAS; functional impairment). Genome-wide association analyses were performed with REGENIE. Heritability was estimated using GCTA-GREML and genetic correlations with bivariate-GREML. Results Phenotypic correlations were moderate across the three measures (Pearson’s r = 0.50 - 0.69). All three scales were found to be under low but significant genetic influence (h2SNP = 0.11 - 0.19) with high genetic correlations between them (rg = 0.79 - 0.87). Conclusions Among individuals with lifetime depression or anxiety, the genetic variants that underlie symptom severity largely overlap with those influencing functional impairment. This suggests that self-reported functional impairment, while clinically relevant for diagnosis and treatment outcomes, does not reflect substantial additional genetic liability beyond that captured by symptom-based measures of depression or anxiety.

  • Open Access

    Co-development of ADHD symptoms and emotional problems from childhood to adulthood: predictors and developmental outcomes

    by Yuan You, Tom McAdams, Helena Zavos, Linlin Zhang, Laurie John Hannigan, Christopher Rayner, Meredith Han, Elisavet Palaiologou

    Objective: Attention-deficit/hyperactivity disorder (ADHD) symptoms and emotional problems frequently co-occur and the magnitude of co-occurrence is known to increase across development. Longitudinal cohort data provides opportunities to understand how and why ADHD symptoms co-develop. Method: Data were drawn from the Twins Early Development Study, which included 13945 twin pairs. Emotional problems and ADHD symptoms were parent-reported using the Strengths and Difficulties Questionnaire and Conners’ Parent Rating scales. We modelled the co-development of ADHD symptoms and emotional problems from ages 4 to 21 using joint trajectory analysis.Results: The four-class joint trajectory model of ADHD symptoms and emotional problems provided the best fit to the data. This included patterns such as both traits remaining consistently low, both traits steadily increasing, and one trait being high while the other remained low. ADHD and externalizing problems polygenic scores, as well as maternal depression, socioeconomic status and home chaos were significant predictors of the joint trajectory of ADHD and emotional problems. The group with consistently low symptoms reported higher educational attainment, fewer emotional problems, and fewer ADHD symptoms at age 26 than the other groups. Individuals with high initial ADHD symptoms in childhood or increasing symptoms from childhood to adulthood reported lowest educational attainment and socioeconomic status in adulthood among all the groups.Conclusion: Our findings suggest that the co-occurrence of ADHD symptoms and emotional problems can follow various developmental trajectories, and these trajectories have distinct early-life predictors and adult outcomes. We discuss these differences with a view to informing intervention targets.

  • Open Access

    Using twin-pairs to assess potential bias in polygenic prediction of externalising behaviours across development

    by Joanna K. Bright, Christopher Rayner, Ze Freeman, Helena M. S. Zavos, Yasmin I. Ahmadzadeh, Essi Viding, Tom A. McAdams

    Prediction from polygenic scores may be confounded by sources of passive gene-environment correlation (rGE; e.g. population stratification, assortative mating, and environmentally mediated effects of parental genotype on child phenotype). Using genomic data from 10 000 twin pairs, we asked whether polygenic scores from the most recent externalising genome-wide association study predict conduct problems, ADHD symptomology and callous-unemotional traits, and whether these predictions are biased by rGE. We ran regression models including within-family and between-family polygenic scores, to separate the direct genetic influence on a trait from environmental influences that correlate with genes (indirect genetic effects). Findings suggested that this externalising polygenic score is a good index of direct genetic influence on conduct and ADHD-related symptoms across development, with minimal bias from rGE, although the polygenic score predicted less variance in CU traits. Post-hoc analyses showed some indirect genetic effects acting on a common factor indexing stability of conduct problems across time and contexts.


  • Open Access

    Physiology and Pharmacology of Effects of GLP-1-based Therapies on Gastric, Biliary and Intestinal Motility

    by Ryan J Jalleh, Chinmay S Marathe, Christopher K Rayner, Karen L Jones, Mahesh M Umapathysivam, Tongzhi Wu, Daniel R Quast, Mark P Plummer, Michael A Nauck, Michael Horowitz

    Glucagon-like peptide-1 (GLP-1) receptor agonists and the dual GLP-1- and glucose-dependent insulinotropic polypeptide receptor co-agonist tirzepatide (referred to here collectively as “GLP-1-based therapy”) are incretin-based therapies being used increasingly in the management of both type 2 diabetes and obesity. They are now recognized to have beneficial effects beyond improved glycemic control and weight loss, including cardiovascular and renal protection. GLP-1-based therapy also slows gastric emptying, which has benefits (lowering postprandial glucose), but also potential risks (eg, hypoglycemia in individuals on insulin or sulphonylurea therapy). Their effects on the gallbladder may also be beneficial, contributing to reducing postprandial triglycerides, but they also potentially increase the risk of biliary disease. In this review, we summarize the effects of GLP-1 and incretin-based therapeutics on gastric, biliary and small intestinal function. An improved understanding of these effects will optimize the use of these drugs.


  • Open Access

    A variance quantitative trait loci map of childhood behaviour: searching for gene-environment interactions in the MoBa cohort

    by Christopher Rayner, Yasmin Iona Ahmadzadeh, Ziada Ayorech, Isabella Badini, Rosa Cheesman, Eivind Ystrom, Tom McAdams

    Background: Gene-environment interaction is likely to contribute to human development, but individual effects are difficult to detect, especially for behavioural outcomes. Genetic variants associated with phenotypic variability (i.e. those with heteroscedastic effects) are potential candidates for tests of interaction. We conduct the first study estimating genetic effects on phenotypic variability in childhood behavioural traits. Methods: We used item response theory models to reduce measurement error in 71 behavioural traits across childhood (ages 6 months - 14 years) in the Norwegian Mother, Father and Child Birth Cohort Study (MoBa; NMEAN: 31,614; NMAX: 58,833) and subsequently tested for genome-wide association (GWA) of mean and variance effects. Downstream analyses included phenome-wide association analyses of independently associated loci, estimation of SNP-based heritability and genetic correlation, and polygenic score analysis in an independent sample, the Twins Early Development Study (NMEAN=1,837). All analyses were repeated in anthropometric traits, to compare with analyses of behaviour. Results: Across the 71 behavioural phenotypes, there were 17 independent genetic variants associated with phenotypic variability, and 44 associated with mean levels. Genome-wide variance effects explained up to 9.7% of the variance (mean h2vGWA=1.8%), whereas mean effects explained up to 15.8% of the phenotypic variance (mean h2GWA=6.0%). In comparison, for anthropometric traits variance effects explained up to 6.7% of the variance in phenotypic variability (mean h2vGWA=2.1%), and mean effects explained up to 42.7% of the phenotypic variance (mean h2GWA=30.5%). There was little evidence that higher variance-based polygenic scores were associated with greater phenotypic variance, or for vPGS-by-environment interactions. Discussion: In keeping with previous analyses of genetic effects on trait variability in anthropometric and biomarker traits, there were fewer variance effects than mean effects for behavioural traits. Nonetheless, several SNPs with effects on phenotypic variance were identified for follow-up analyses. Standard GWA and PGS analyses require large samples. It is likely that even larger samples will be required to comprehensively detect variance effects involved in childhood behaviour. We have provided an extensive summary of the phenotypes assessed in MoBa accompanied by GWA summary statistics made available for future GWA meta-analyses of childhood behavioural traits.

  • Open Access

    A repeated measures GWAS in relatives: detecting age-specific genetic effects on maternal depression

    by Christopher Rayner, Tom McAdams, Eivind Ystrom, Ziada Ayorech

    Background: Genome-wide association studies (GWAS) of depression typically rely on cross-sectional designs, using lifetime history (LTH) of a diagnosis as the primary outcome. While this strategy has been essential towards accumulating the samples required to detect the individually small genetic effects on depression, it involves strong assumptions that the variants important for depression risk are identical across long stretches of life. Furthermore, heterogeneity in the presentation and aetiology of depression is rarely accounted for - as single cohorts are rarely large enough to provide sufficient statistical power. Longitudinal cohorts provide opportunities towards understanding how genetic effects on depression vary across time and contexts. Linear mixed models that account for between person (relatedness) and within person (multiple measures of the same individual) correlations can be applied to repeatedly measured outcomes across time to estimate age-specific genetic effects, known as a repeated measures GWAS (RmGWAS). Methods: We used data from Mothers who participated in the Norwegian Mother Father and Child study (MoBa) - Norwegian women who have all experienced the psycho-social experience of childbirth. We restructured the Hopkins Symptoms Checklist Depression scores for 55,287 mothers by age, producing an accelerated longitudinal design with 323,134 depression observations across the lifecourse (age range: 15.9, 60.12 years old). We implemented RmGWAS to estimate genetic effects on depression symptoms at age 30, and the linear change in age (variant by age interaction). We then used RmGWAS estimates to compute age-specific genetic effects (GWASt , for t={20, 25, 30, 35, 40, 45, 50} ). For comparison, we performed a cross-sectional GWAS using LTH depression assessed in the same sample (GWASLTH). Summary statistics for GWASt={20, 25, 30, 35, 40, 45, 50} and GWASLTH were compared using heritability, genetic correlation, and polygenic index (PGI) analyses.Results: Our RmGWAS detected one genetic variant associated with depression symptoms at age 30, but none associated with linear change over time. The SNP-based heritability (h2SNP) of GWASt ranged from (.01 to .05), whereas for GWASLTH estimates were higher (h2SNP≈.15). The fixed effect PGIt on Yt was β=.03 (95% CI: .03, .04; p=8.5e-45), with a marginal incremental R2=.008, and a conditional incremental R2=.014. For PGILTH the fixed effect on YLTH was OR=0.98 (95% CI: .92-1.04; p=4.5e-01) with an incremental of R2=.001. Discussion: Here we illustrate the potential of longitudinal data on genotyped relatives for revealing the genetic underpinnings of symptom variability across the life course. Using a leave one out approach in the sample of MoBa mothers, we detected a statistically significant effect of PGIt, but no effect of PGI(LTH). The gains observed in these analyses are likely due to the boost in statistical power from the repeated measures approach. More complex models, which incorporate the non-linear effects of age and other genetic effect modifiers, are likely to provide greater age- and context-related specificity for genetic effect estimates. Future work will build on this model to further improve the polygenic prediction and mechanistic understanding of mental health across development. In summary, this novel approach reduces some of the common sources of heterogeneity in depression GWAS by exploiting repeated assessments of pregnant women living in the Norwegian welfare state.